The antipsychotic drug pimozide promotes apoptosis through the RAF/ERK pathway and enhances autophagy in breast cancer cells

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–15. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Yardley DA. Drug resistance and the role of combination chemotherapy in improving patient outcomes. Int J Breast Cancer. 2013;2013:1–15. doi:10.1155/2013/137414.
   Google Scholar
• Cuzick J, Baum M. Tamoxifen and contralateral breast cancer. Lancet. 1985;2(8449):282. doi:10.1016/S0140-6736(85)90338-1.
   PubMed Web of Science ®Google Scholar
• Del Barco S, Vazquez-Martin A, Cufí S, Oliveras-Ferraros C, Bosch-Barrera J, Joven J, Martin-Castillo B, JA M. Metformin: multi-faceted protection against cancer. Oncotarget. 2011;2(12):896–917. doi:10.18632/oncotarget.387.
   PubMedGoogle Scholar
• Boguski MS, Mandl KD, Sukhatme VP. Drug discovery. Repurposing with a difference. Sci. 2009;324(5933):1394–1395. doi:10.1126/science.1169920.
   PubMed Web of Science ®Google Scholar
• Bashir MN. Epidemiology of prostate cancer. Asian Pac J Cancer Prev. 2015;16(13):5137–5141. doi:10.7314/APJCP.2015.16.13.5137.
   PubMedGoogle Scholar
• Hossain MA, Kim DH, Jang JY, Kang YJ, Yoon JH, Moon JO, Chung HY, Kim GY, Choi YH, Copple BL, et al. Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model. Int J Oncol. 2012;40(4):1298–1304. doi:10.3892/ijo.2011.1304.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li Y, Niu Z, Zong Y, Wang M, Yao L, Lu Z, Liao Q, Zhao Y. Atorvastatin (lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages. J Exp Clin Cancer Res. 2016;35(1):33. doi:10.1186/s13046-016-0304-4.
   PubMedGoogle Scholar
• Ren Y, Tao J, Jiang Z, Guo D, Tang J. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway. Life Sci. 2018;209:267–273. doi:10.1016/j.lfs.2018.08.027.
   PubMed Web of Science ®Google Scholar
• Cai N, Zhou W, Ye LL, Chen J, Liang QN, Chang G, Chen JJ. The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression. Am J Transl Res. 2017;9:3853–3866.
   PubMed Web of Science ®Google Scholar
• Fako V, Yu Z, Henrich CJ, Ransom T, Budhu AS, Wang XW. Inhibition of Wnt/β-catenin signaling in hepatocellular carcinoma by an antipsychotic drug pimozide. Int J Biol Sci. 2016;12(7):768–775. doi:10.7150/ijbs.14718.
   PubMed Web of Science ®Google Scholar
• Elmaci I, Altinoz MA. Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma. Crit Rev Oncol Hematol. 2018;128:96–109. doi:10.1016/j.critrevonc.2018.06.004.
   PubMed Web of Science ®Google Scholar
• Tian H, Yin L, Ding K, Xia YY, Wang XH, Wu JZ, He X. Raf1 is a prognostic factor for progression in patients with non‑small cell lung cancer after radiotherapy. Oncol Rep. 2018;39:1966–1974. doi:10.3892/or.2018.6277.
   PubMed Web of Science ®Google Scholar
• Bertolesi GE, Shi C, Elbaum L, Jollimore C, Rozenberg G, Barnes S, Kelly ME. The Ca 2+ Channel Antagonists Mibefradil and Pimozide Inhibit Cell Growth via Different Cytotoxic Mechanisms. Mol Pharmacol. 2002;62(2):210–219. doi:10.1124/mol.62.2.210.
   PubMed Web of Science ®Google Scholar
• Desideri E, Cavallo AL, Baccarini M. Alike but different: RAF paralogs and their signaling outputs. Cell. 2015;161(5):967–970. doi:10.1016/j.cell.2015.04.045.
   PubMed Web of Science ®Google Scholar
• Jeric I, Maurer G, Cavallo AL, Raguz J, Desideri E, Tarkowski B, Parrini M, Fischer I, Zatloukal K, Baccarini M. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nat Commun. 2016;7(1):13781. doi:10.1038/ncomms13781.
   PubMedGoogle Scholar
• Ma SQ, Cao BR, Zhang H, Luo LP, Ren Y, Hu T, Chen CM. The lack of raf-1 kinase feedback regulation enhances antiapoptosis in cancer cells. Oncogene. 2017;36(14):2014–2022. doi:10.1038/onc.2016.384.
   PubMed Web of Science ®Google Scholar
• Castro L, Alves S, Chaves SR, Costa JL, Soares P, Preto A. RAF-1 promotes survival of thyroid cancer cells harboring RET/PTC1 rearrangement independently of ERK activation. Mol Cell Endocrinol. 2015;415:64–75. doi:10.1016/j.mce.2015.08.006.
   PubMed Web of Science ®Google Scholar
• Dai H, Chen H, Liu W, You Y, Tan J, Yang A, Lai X, Bie P. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study. J Cancer Res Clin Oncol. 2016;142(10):2107–2117. doi:10.1007/s00432-016-2206-4.
   PubMed Web of Science ®Google Scholar
• Feng R, Gong J, Wu L, Wang L, Zhang B, Liang G, Zheng H, Xiao H. MAPK and Hippo signaling pathways crosstalk via the RAF-1/MST-2 interaction in malignant melanoma. Oncol Rep. 2017;38(2):1199–1205. doi:10.3892/or.2017.5774.
   PubMed Web of Science ®Google Scholar
• Liu B, Xing X, Li X, Guo Q, Xu T, Xu K. ZNF259 promotes breast cancer cells invasion and migration via ERK/GSK3β/snail signaling. Cancer Manag Res. 2018;10:3159–3168. doi:10.2147/CMAR.S174745.
   PubMed Web of Science ®Google Scholar
• Ren H, Ma J, Si L, Ren B, Chen X, Wang D, Hao W, Tang X, Li D, Zheng Q. Low dose of acacetin promotes breast cancer MCF-7 cells proliferation through the activation of ERK/PI3K/AKT and cyclin signaling pathway. Recent Pat Anticancer Drug Discov. 2018;13(3):368–377. doi:10.2174/1574892813666180420154012.
   PubMed Web of Science ®Google Scholar
• Decuypere JP, Parys JB, Bultynck G. Regulation of the autophagic bcl-2/beclin 1 interaction. Cells. 2012;1(3):284–312. doi:10.3390/cells1030284.
   PubMedGoogle Scholar
• Basit F, Cristofanon S, Fulda S. Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ. 2013;20(9):1161–1173. doi:10.1038/cdd.2013.45.
   PubMed Web of Science ®Google Scholar
• Liu Y, Fan D. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model. Food Funct. 2018;9(11):5513–5527. doi:10.1039/C8FO01122B.
   PubMed Web of Science ®Google Scholar
• Cao C, Huang W, Zhang N, Wu F, Xu T, Pan X, Peng C, Han B. Narciclasine induces autophagy-dependent apoptosis in triple-negative breast cancer cells by regulating the AMPK-ULK1 axis. Cell Prolif. 2018;51(6):e12518. doi:10.1111/cpr.12518.
   PubMed Web of Science ®Google Scholar
• Ni Y, Wu S, Wang X, Zhu G, Chen X, Ding Y, Jiang W. Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway. J Cell Biochem. 2018;119(7):6104–6112. doi:10.1002/jcb.26808.
   PubMed Web of Science ®Google Scholar
• Weng JR, Chiu CF, Hu JL, Feng CH, Huang CY, Bai LY, Sheu JH. A sterol from soft coral induces apoptosis and autophagy in MCF-7 breast cancer cells. Mar Drugs. 2018;16(7):e238. doi:10.3390/md16070238.
   PubMed Web of Science ®Google Scholar
• Gyorffy B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer, comput. Struct Biotechnol J. 2021;19:4101–4109. doi:10.1016/j.csbj.2021.07.014.
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Rodriguez IP, BVSK C, Varambally S. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002.
   PubMed Web of Science ®Google Scholar
• Cao HY, Wu YH, Zhou XZ, Zheng XF, Jiang G. In silico prediction and validation of oxygen-regulated protein N-myc downstream regulated gene 3 and virtual screening of competitive inhibitors of L-Lactate as therapeutics. Lett Drug Des Discov. 2018;16(6):637–644. doi:10.2174/1570180815666180816130621.
   Web of Science ®Google Scholar
• Strobl JS, Kirkwood KL, Lantz TK, Lewine MA, Peterson VA, Worley JF. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Cancer Res. 1990;50(17):5399–5405.
   PubMed Web of Science ®Google Scholar
• Wiklund ED, Catts VS, Catts SV, Ng TF, Whitaker NJ, Brown AJ, Lutze-Mann LH. Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target. Int J Cancer. 2010;126(1):28–40. doi:10.1002/ijc.24813.
   PubMed Web of Science ®Google Scholar
• Roos A, Dhruv HD, Peng S, Inge LJ, Tuncali S, Pineda M, Millard N, Mayo Z, Eschbacher JM, Loftus JC, et al. EGFRvIII–Stat5 signaling enhances glioblastoma cell migration and survival. Mol Cancer Res. 2018;16(7):1185–1195. doi:10.1158/1541-7786.MCR-18-0125.
   PubMed Web of Science ®Google Scholar
• Romano D, Nguyen LK, Matallanas D, Halasz M, Doherty C, Kholodenko BN, Kolch W. Protein interaction switches coordinate raf-1 and MST2/Hippo signalling. Nat Cell Biol. 2014;16(7):673–684. doi:10.1038/ncb2986.
   PubMed Web of Science ®Google Scholar
• Zielke S, Meyer N, Mari M, Abou-El-Ardat K, Reggiori F, van Wijk SJL, Kogel D, Fulda S, van Wijk SJL. Loperamide, pimozide, and STF-62247 trigger autophagy-dependent cell death in glioblastoma cells. Cell Death Disease. 2018;9(10):994. doi:10.1038/s41419-018-1003-1.
   PubMed Web of Science ®Google Scholar
• Basole CP, Nguyen RK, Lamothe K, Vang A, Clark R, Baillie GS, Epstein PM, Brocke S. PDE8 controls CD4+ T cell motility through the PDE8A-Raf-1 kinase signaling complex. Cell Signal. 2017;40:62–72. doi:10.1016/j.cellsig.2017.08.007.
   PubMed Web of Science ®Google Scholar
• Ugland H, Naderi S, Brech A, Collas P, Blomhoff HK. cAMP induces autophagy via a novel pathway involving ERK, cyclin E and beclin 1. Autophagy. 2011;7(10):1199–1211. doi:10.4161/auto.7.10.16649.
   PubMed Web of Science ®Google Scholar
• Strobl JS, Melkoumian Z, Peterson VA, Hylton H. The cell death response to γ-radiation in MCF-7 cells is enhanced by a neuroleptic drug, pimozide. Breast Cancer Res Treat. 1998;51(1):83–95. doi:10.1023/A:1006046604062.
   PubMed Web of Science ®Google Scholar
• Goncalves JM, Silva CAB, Rivero ERC, Cordeiro MMR. Inhibition of cancer stem cells promoted by pimozide. Clin Exp Pharmacol Physiol. 2019;2(2):116–125. doi:10.1111/1440-1681.13049.
   Google Scholar
• Kim JY, Park Y, Lee BM, Kim HS, Yoon S. P-gp inhibition by the anti-psychotic drug pimozide increases apoptosis, as well as expression of prb and ph2ax in highly drug-resistant kbv20c cells. Anticancer Res. 2017;38(10):5685–5692. doi:10.21873/anticanres.12905.
   Web of Science ®Google Scholar
• Zhou W, Chen MK, Yu HT, Zhong ZH, Cai N, Chen GZ, Zhang P, Chen JJ. The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation. Int J Oncol. 2016;48(1):322–328. doi:10.3892/ijo.2015.3229.
   PubMed Web of Science ®Google Scholar
• Nelson EA, Walker SR, Weisberg E, Bar-Natan M, Barrett R, Gashin LB, Terrell S, Klitgaard JL, Santo L, Addorio MR, et al. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood. 2011;117(12):3421–3429. doi:10.1182/blood-2009-11-255232.
   PubMed Web of Science ®Google Scholar
• Kostic M, Katoshevski T, Sekler I. Allosteric regulation of NCLX by mitochondrial membrane potential links the metabolic state and Ca signaling in mitochondria. Cell Rep. 2018;25(12):3465–3475. doi:10.1016/j.celrep.2018.11.084.
   PubMed Web of Science ®Google Scholar
• Zhang P, Zheng Z, Ling L, Yang X, Zhang N, Wang X, Hu M, Xia Y, Ma Y, Yang H, et al. w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway. Autophagy. 2017;13(7):1093–1112. doi:10.1080/15548627.2017.1319039.
   PubMed Web of Science ®Google Scholar
• Kim KY, Park KI, Kim SH, Yu SN, Park SG, Kim YW, Seo YK, Ma JY, Ahn SC. Inhibition of autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human prostate cancer cells. Int J Mol Sci. 2017;18(5):E1088. doi:10.3390/ijms18051088.
   PubMed Web of Science ®Google Scholar
• Guo Y, Li Y, Wang FF, Xiang B, Huang XO, Ma HB, Gong YP. The combination of nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway. Int J Biochem Cell Biol. 2019;106:8–20. doi:10.1016/j.biocel.2018.10.008.
   PubMed Web of Science ®Google Scholar
• Skalhegg BS, Landmark BF, Doskeland SO, Hansson V, Lea T, Jahnsen T. Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3‘,5‘-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J Biol Chem. 1992;267(22):15707–15714. doi:10.1016/S0021-9258(19)49593-8.
   PubMed Web of Science ®Google Scholar
• Persaud L, Mighty J, Zhong X, Francis A, Mendez M, Muharam H, Redenti SM, Das D, Aktas BH, Sauane M. IL-24 promotes apoptosis through cAMP-dependent PKA pathways in human breast cancer cells. Int J Mol Sci. 2018;19(11):3561. doi:10.3390/ijms19113561.
   PubMed Web of Science ®Google Scholar
• Raimondi M, Cesselli D, Di Loreto C, La Marra F, Schneider C, Demarchi F. USP1 (ubiquitin specific peptidase 1) targets ULK1 and regulates its cellular compartmentalization and autophagy. Autophagy. 2019;15(4):613–630. doi:10.1080/15548627.2018.1535291.
   PubMed Web of Science ®Google Scholar
• Mistry H, Hsieh G, Buhrlage SJ, Huang M, Park E, Cuny GD, Galinsky I, Stone RM, Gray NS, D’Andrea AD, et al. Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells. Mol Cancer Ther. 2013;12(12):2651–62. doi:10.1158/1535-7163.MCT-13-0103-T.
   PubMed Web of Science ®Google Scholar
• Sachdeva R, Wu MG, Smiljanic S, Kaskun O, Ghannad-Zadeh K, Celebre A, Isaev K, Morrissy AS, Guan J, Tong JF, et al. ID1 is critical for tumorigenesis and regulates chemoresistance in glioblastoma. Cancer Res. 2019;79(16):4057–4071. doi:10.1158/0008-5472.CAN-18-1357.
   PubMed Web of Science ®Google Scholar
• Cheung HW, Ling MT, Tsao SW, Wong YC, Wang XH. Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Carcinogenesis. 2004;25(6):881–887. doi:10.1093/carcin/bgh087.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Dexheimer TS, Ai YX, Liang Q, Villamil MA, Inglese J, Maloney DJ, Jadhav A, Simeonov A, Zhuang ZH. Selective and cell-active inhibitors of the USP1/UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells. Chem Biol. 2011;18(11):1390–400. doi:10.1016/j.chembiol.2011.08.014.
   PubMedGoogle Scholar
• Fortney K, Griesman J, Kotlyar M, Pastrello C, Angeli M, Sound-Tsao M, Jurisica I, Tucker-Kellogg G. Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data. PLoS Comput Biol. 2015;11(3):e1004068. doi:10.1371/journal.pcbi.1004068.
   PubMed Web of Science ®Google Scholar
• el-H D, Pickard A, Srivastava K, McCrudden CM, Gross SR, Lloyd S, Zhang SD, Margariti A, Morgan R, Rudland PS, et al. The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. Oncotarget. 2018;9(79):34889–34910. doi:10.18632/oncotarget.26175.
   PubMedGoogle Scholar